ACARIX BTU Stock Overview
A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Acarix AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.70 |
| 52 Week High | SEK 0.85 |
| 52 Week Low | SEK 0.63 |
| Beta | 1.63 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACARIX BTU | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -0.8% | 1.1% | 1.9% |
| 1Y | n/a | 20.7% | 24.3% |
Return vs Industry: Insufficient data to determine how ACARIX BTU performed against the Swedish Medical Equipment industry.
Return vs Market: Insufficient data to determine how ACARIX BTU performed against the Swedish Market.
Price Volatility
| ACARIX BTU volatility | |
|---|---|
| ACARIX BTU Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: ACARIX BTU has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ACARIX BTU's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 20 | Fred Colen | www.acarix.com |
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Acarix AB (publ) Fundamentals Summary
| ACARIX BTU fundamental statistics | |
|---|---|
| Market cap | SEK 203.97m |
| Earnings (TTM) | -SEK 78.39m |
| Revenue (TTM) | SEK 6.72m |
30.4x
P/S Ratio-2.6x
P/E RatioIs ACARIX BTU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACARIX BTU income statement (TTM) | |
|---|---|
| Revenue | SEK 6.72m |
| Cost of Revenue | SEK 1.12m |
| Gross Profit | SEK 5.60m |
| Other Expenses | SEK 83.99m |
| Earnings | -SEK 78.39m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 15, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 83.30% |
| Net Profit Margin | -1,166.49% |
| Debt/Equity Ratio | 0% |
How did ACARIX BTU perform over the long term?
See historical performance and comparison